ClinicalTrials.gg
Drug

Hydroxyethyl Starch Derivatives clinical trials

Also written Hydroxyethyl starch, Volulyte and HES 130/0.4.

A group of medicines. HES 130-0.4 (16 studies) is counted on its own page; this page counts the studies that name Hydroxyethyl Starch Derivatives itself.

studies test it
46
open now
5
in phase 3
7
first study started
2004

How each study uses Hydroxyethyl Starch Derivatives is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Hydroxyethyl Starch Derivatives studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

6% hydroxyethyl starch 130/0.4
5
Intravenous HES
4
Volulyte 6%
4
HES
3
Voluven
3

Brand

Volulyte
4
Hespan
1

Development codes

HES 130/0.4
3
HES 10%
1

Other names

Hydroxyethyl starch
7
Hydroxyethyl starch 130/0.4
6
Hetastarch
2
Hydroxyethylstarch 130/0.4
2

Medicines filed under Hydroxyethyl Starch Derivatives

As reviewed, so not every one. Each counts its studies on its own page, not here.

Studies by the year they started

45 studies that test it; most in 2009 (7)

Studies that test Hydroxyethyl Starch Derivatives, by start year
YearStudies
20041
20052
20061
20072
20097
20101
20111
20122
20135
20141
20154
20166
20173
20191
20202
20231
20243
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 2
1
Phase 3
7
Phase 4
18
No phase
19

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 39

Konkuk University Medical Center (6) · Fresenius Kabi (5) · The Cleveland Clinic (2) · General Hospital of Ningxia Medical University (2) · Seoul National University Hospital (2) · Tanta University (1) · Queen Fabiola Children's University Hospital (1) · Indiana University (1)

Often tested with

Tested in the same studies.

Albumins human (2) · Sodium Chloride (2) · Ringer's Lactate (2) · Hydrocortisone (1) · Crystalloid Solutions (1) · SIC-8000 (1) · Whole blood (1) · Bupivacaine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Hydroxyethyl Starch Derivatives.

Studies

Open first, then newest update. How each study uses Hydroxyethyl Starch Derivatives is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 46

See all 46 studies that test Hydroxyethyl Starch Derivatives →

Given beside what is tested · 1 — Hydroxyethyl Starch Derivatives is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Hydroxyethyl Starch Derivatives

Codes

What other systems call Hydroxyethyl Starch Derivatives · ClinicalTrials.gg INT007633

  • MeSH (NLM) D006895Hydroxyethyl Starch DerivativesConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 1GVO236S58HYDROXYETHYL STARCH 130/0.4Confirmed FDA, NLM
  • RxNorm 1363352One source FDA

Also registered as hetastarch (UNII 875Y4127EA · RxNorm 5531) and pentastarch (UNII MOQ3RNM0SV · RxNorm 816249).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.